This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, B. Articles by Marks, J. D. Search for Related Content PubMed PubMed Citation Articles by Liu, B. Articles by Marks, J. D.

Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells

¹ Departments of Anesthesia and Pharmaceutical Chemistry,
² Comprehensive Cancer Center, and
³ Department of Urology, University of California at San Francisco, San Francisco General Hospital, and
⁴ California Pacific Medical Center Research Institute, San Francisco, California

The identification of tumor-specific cell surface antigens is a critical step toward the development of targeted therapeutics for cancer. The epitope space at the tumor cell surface is highly complex, composed of proteins, carbohydrates, and other membrane-associated determinants including post-translational modification products, which are difficult to probe by approaches based on gene expression. This epitope space can be efficiently mapped by complementary monoclonal antibodies. By selecting human antibody gene diversity libraries directly on the surface of prostate cancer cells, we have taken a functional approach to identifying fully human, tumor-specific monoclonal antibodies without prior knowledge of their target antigens. Selection conditions have been optimized to favor tumor-specific antibody binding and internalization. To date, we have discovered >90 monoclonal antibodies that specifically bind and enter prostate cancer cells, with little or no binding to control cells. These antibodies are able to efficiently deliver intracellular payloads when attached to nanoparticles such as liposomes. In addition, a subset of the antibodies displayed intrinsic antiproliferative activity. These tumor-specific internalizing antibodies are likely to be useful for targeted therapeutics either alone or in combination with effector molecules. The antigens they bind constitute a tumor-specific internalizing epitope space that is likely to play a significant role in cancer cell homeostasis. Targeting components of this epitope space may facilitate development of immunotherapeutic and small molecule-based strategies as well as the use of other therapeutic agents that rely upon delivery to the interior of the tumor cell.

This article has been cited by other articles:

				S. Bidlingmaier, J. He, Y. Wang, F. An, J. Feng, D. Barbone, D. Gao, B. Franc, V. C. Broaddus, and B. Liu Identification of MCAM/CD146 as the Target Antigen of a Human Monoclonal Antibody that Recognizes Both Epithelioid and Sarcomatoid Types of Mesothelioma Cancer Res., February 15, 2009; 69(4): 1570 - 1577. [Abstract] [Full Text] [PDF]

				F. An, D. C. Drummond, S. Wilson, D. B. Kirpotin, S. L. Nishimura, V. C. Broaddus, and B. Liu Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies Mol. Cancer Ther., March 1, 2008; 7(3): 569 - 578. [Abstract] [Full Text] [PDF]

				A. Roth, D. C. Drummond, F. Conrad, M. E. Hayes, D. B. Kirpotin, C. C. Benz, J. D. Marks, and B. Liu Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells Mol. Cancer Ther., October 1, 2007; 6(10): 2737 - 2746. [Abstract] [Full Text] [PDF]

				B. Liu Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA Brief Funct Genomic Proteomic, July 31, 2007; (2007) elm015v1. [Abstract] [Full Text] [PDF]

				W. Ruan, A. Sassoon, F. An, J. P. Simko, and B. Liu Identification of Clinically Significant Tumor Antigens by Selecting Phage Antibody Library on Tumor Cells in Situ Using Laser Capture Microdissection Mol. Cell. Proteomics, December 1, 2006; 5(12): 2364 - 2373. [Abstract] [Full Text] [PDF]

				J. R. McWhirter, A. Kretz-Rommel, A. Saven, T. Maruyama, K. N. Potter, C. I. Mockridge, E. P. Ravey, F. Qin, and K. S. Bowdish Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation PNAS, January 24, 2006; 103(4): 1041 - 1046. [Abstract] [Full Text] [PDF]

				P. Carter, L. Smith, and M. Ryan Identification and validation of cell surface antigens for antibody targeting in oncology Endocr. Relat. Cancer, December 1, 2004; 11(4): 659 - 687. [Abstract] [Full Text] [PDF]